Evidence map›Paper›PMID 21540258›Full record

ArticleBMJ (Clinical research ed.)2011

Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study.

Martin H Thornhill, Mark J Dayer, Jamie M Forde, G Ralph Corey, Vivian H Chu, David J Couper, Peter B Lockhart

Open access · hybridAbstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 6 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 6 syntheses or guidelines pooled it, 245 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Epidemiology of infective endocarditis beforeTherapeutic advances in cardiovascular disease
    Pooled it
  7. Review
  8. Article
  9. Article
  10. Article
  11. Infective Endocarditis Risk After Invasive Dental Procedures.Mayo Clinic proceedings. Innovations, quality & outcomes · 2025
    Article
  12. Article
  13. Review
  14. Article
  15. Is topical antibiotic use necessary to prevent surgical site infection following oculoplastic surgery?Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  16. Endocarditis prevention: time for a review of NICE guidance.The Lancet regional health. Europe · 2024
    Review
  17. Review
  18. Article
  19. Infective endocarditis following invasive dental procedures: IDEA case-crossover study.Health technology assessment (Winchester, England) · 2022
    Observational
  20. Infective endocarditis in paediatric population.European journal of pediatrics · 2021
    Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Martin H ThornhillUniversity of Sheffield School of Clinical Dentistry, Sheffield S10 2TA, UK. m.thornhill@sheffield.ac.uk
Mark J Dayer
Jamie M Forde
G Ralph Corey
Vivian H Chu
David J Couper
Peter B Lockhart
Duke University · USCarolinas Medical Center · USTaunton & Somerset NHS Foundation Trust · GBThe Coordinating Center · USUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo quantify the change in prescribing of antibiotic prophylaxis before invasive dental procedures for patients at risk of infective endocarditis, and any concurrent change in the incidence of infective endocarditis, following introduction of a clinical guideline from the National Institute for Health and Clinical Excellence (NICE) in March 2008 recommending the cessation of antibiotic prophylaxis in the United Kingdom.

designBefore and after study.

settingEngland. Population All patients admitted to hospital in England with a primary or secondary discharge diagnosis of acute or subacute infective endocarditis.

main outcome measuresMonthly number of prescriptions for antibiotic prophylaxis consisting of a single 3 g oral dose of amoxicillin or a single 600 mg oral dose of clindamycin, and monthly number of cases of infective endocarditis, infective endocarditis related deaths in hospital, or cases of infective endocarditis with a possible oral origin for streptococci.

resultsAfter the introduction of the NICE guideline there was a highly significant 78.6% reduction (P < 0.001) in prescribing of antibiotic prophylaxis, from a mean 10,277 (SD 1068) prescriptions per month to 2292 (SD 176). Evidence that the general upward trend in cases of infective endocarditis before the guideline was significantly altered after the guideline was lacking (P = 0.61). Using a non-inferiority test, an increase in the number of cases of 9.3% or more could be excluded after the introduction of the guideline. Similarly an increase in infective endocarditis related deaths in hospital of 12.3% or more could also be excluded.

conclusionDespite a 78.6% reduction in prescribing of antibiotic prophylaxis after the introduction of the NICE guideline, this study excluded any large increase in the incidence of cases of or deaths from infective endocarditis in the two years after the guideline. Although this lends support to the guideline, ongoing data monitoring is needed to confirm this, and further clinical trials should determine if antibiotic prophylaxis still has a role in protecting some patients at particularly high risk.

Indexed as

Acute DiseaseAdministration, OralAmoxicillinAnti-Bacterial AgentsAntibiotic ProphylaxisClindamycinEndocarditisHospitalizationHumansPractice Guidelines as TopicAmoxicillinAnti-Bacterial AgentsClindamycin

Identifiers

PMID21540258
PMCPMC3086390
OpenAlexW2002582186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.